Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily
Sarepta Therapeutics (SRPT) Ownership Overview
4.09% Insiders
29.29% Mutual Funds
31.39% Other Institutional Investors
20.47% ETFs
14.75% Public Companies and
Individual Investors
The ownership structure of Sarepta Therapeutics (SRPT) stock is a mix of institutional, retail, and individual investors. Approximately 81.16% of the company’s stock is owned by Institutional Investors, 4.09% is owned by Insiders, and 14.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 03, 2024 | xxxxxxxxxxxxx | $822100 | |
| Aug 20, 2024 | Michael Andrew Chambers Director | xxxxxxxxxxxxx | $4955728 |
| Mar 11, 2024 | Kathryn Jean Boor Director | xxxxxxxxxxxxx | $93550 |
| Mar 11, 2024 | Hans Lennart Rudolf Wigzell Director | xxxxxxxxxxxxx | $1848795 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $715869 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $999244 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1209809 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2267377 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,346,165 | Institution | 8.74% | 1,112,877,641 | |
| 7,801,532 | Institution | 8.17% | 1,040,256,277 | |
| 6,252,701 | Institution | 6.55% | 833,735,151 | |
| 3,181,688 | Insider | 3.33% | 424,246,278 | |
| 3,013,719 | Institution | 3.16% | 401,849,291 | |
| 2,580,000 | Institution | 2.70% | 344,017,200 | |
| 2,177,973 | Institution | 2.28% | 290,410,920 | |
| 2,099,199 | Institution | 2.20% | 279,907,195 | |
| 1,654,174 | Institution | 1.73% | 220,567,561 | |
| 1,264,046 | Institution | 1.32% | 168,547,894 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,801,532 | Institution | 8.17% | 1,040,256,277 | |
| 2,177,973 | Institution | 2.28% | 290,410,920 | |
| 2,099,199 | Institution | 2.20% | 279,907,195 | |
| 1,654,174 | Institution | 1.73% | 220,567,561 | |
| 1,264,046 | Institution | 1.32% | 168,547,894 | |
| 1,071,372 | Institution | 1.12% | 142,856,742 | |
| 988,982 | Institution | 1.04% | 131,870,860 | |
| 891,900 | Institution | 0.93% | 118,925,946 | |
| 496,707 | Institution | 0.52% | 66,230,911 | |
| 493,722 | Institution | 0.52% | 65,832,891 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,062,229 | Institution | 3.21% | 408,317,615 | |
| 2,843,172 | Institution | 2.98% | 358,239,672 | |
| 2,272,396 | Institution | 2.38% | 286,321,896 | |
| 1,488,615 | Institution | 1.56% | 205,339,553 | |
| 1,418,937 | Institution | 1.49% | 178,786,062 | |
| 1,247,467 | Institution | 1.31% | 157,180,842 | |
| 773,230 | Institution | 0.81% | 103,102,488 | |
| 617,201 | Institution | 0.65% | 82,297,581 | |
| 512,377 | Institution | 0.54% | 68,320,349 | |
| 474,698 | Institution | 0.50% | 63,296,231 |
FAQ
Who Owns Sarepta Therapeutics (SRPT)?
According to the latest TipRanks data, approximately 31.39% of the company's stock is held by institutional investors, 4.09% is held by insiders, and 14.75% is held by retail investors.
What percentage of Sarepta Therapeutics (SRPT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.39% of Sarepta Therapeutics (SRPT) stock is held by institutional investors.
What percentage of Sarepta Therapeutics (SRPT) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.75% of Sarepta Therapeutics (SRPT) stock is held by retail investors.
Who owns the most shares of Sarepta Therapeutics (SRPT)?
Vanguard owns the most shares of Sarepta Therapeutics (SRPT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.